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Aim: Allergic fungal rhinosinusitis (AFRS) is a distinct clinical and pathological
entity. Various recurrence rates have been reported in literature, but the
contralateral disease development in unilateral AFRS cases has not been
specifically investigated. The aim of the current study was to analyze the outcomes
in unilateral cases of AFRS.
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Patients and methods: We have conducted a retrospective review of all patients
who underwent endoscopic sinus surgery from January 2012 to March 2015 at our
institution. AFRS patients’ demographics, diagnosis, management, and follow-up
data were collected.
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Statistical analysis: Analyses were performed using IBM SPSS 22.0 for
Windows. The prevalence of AFRS and unilateral AFRS was calculated. In case of
unilateral AFRS, further descriptive analysis was performed.

a

b

Setting and design: This is a retrospective analysis conducted at a tertiary care
institution.

Results: AFRS was diagnosed in 52 (38.2%) out of 136 cases of chronic
rhinosinusitis with or without nasal polyps treated with endoscopic sinus
surgery. Out of the 52 AFRS patients, 16 (30.8%) cases presented with unilateral
AFRS, and all were treated with standard surgical and medical therapy. During a
mean follow-up of 24.8 months, nine (56.2%) of the 16 unilateral cases remained
disease-free, four (25%) developed AFRS on the contralateral side, two (12.5%)
had recurrent ipsilateral AFRS, and one (6.25%) had both ipsilateral recurrence
and contralateral development of AFRS.
Conclusion: Postoperative development of contralateral disease in unilateral
AFRS cases is not uncommon, and it frequently occurs even without involvement
of the originally operated side. These findings require special attention in patients’
management, follow-up, and counseling.
Keywords: bilateral disease, chronic sinusitis, contralateral development,
endoscopic sinus surgery, follow-up, laterality, predominant nasal polyps,
prevalence, recurrence rate, sinonasal polyposis
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Introduction

Allergic fungal rhinosinusitis (AFRS) is a noninvasive
form of fungal chronic rhinosinusitis (CRS) with distinct
clinical and pathological findings and a high tendency for
recurrence. [1–4] The first description of this disease
comes from the observation of McCarthy and Pepys in
1971, [5] when they reported a patient with allergic
bronchopulmonary aspergillosis having associated sinonasal
disease. In 1981, Miller et al. described the condition as ‘allergic
aspergillosis of paranasal sinuses’, a disease entity
similar to allergic bronchopulmonary aspergillosis. [6] In 1983,
Katzenstein et al. first isolated the allergic mucin and termed
this disease as allergic fungal sinusitis, [7] which is now
better known as AFRS. [8–10] Since its description, this
disease entity has been extensively studied but continues to
pose challenges in diagnosis and management. [11–13]
Over the years, various diagnostic criteria have been
proposed for diagnosis of AFRS, out of which the criteria
described by Bent and Kuhn [14] are widely accepted. The
following major criteria were proposed for diagnosis: (a)
type 1 (IgE-mediated) hypersensitivity reaction; (b) nasal
polyposis; (c) characteristic computed tomography (CT)
scan finding; (d) eosinophilic mucin; and (e) positive fungal
culture or smear. The percentage of strictly unilateral AFRS
varies in literature, and was reported to be more or less

common than bilateral disease. [2,15,16]
Unilateral AFRS seems to be a challenging pathology to
understand; if AFRS represents only an allergic reaction,
then unilateral AFS should hardly exist [9,17,18]. In addition,
despite the advancement in medical and surgical strategies,
recurrence in AFRS in general poses another challenging
problem with reported incidence that eventually can reach
more than 60%. [19,20]
The objective of this study was to analyze the
contralateral outcome pattern in unilateral AFRS cases, a
matter
that,
to
the
best
of
our
knowledge,
has
not
been specifically investigated in literature before. This information may have an
impact on patients’ counseling, management, and/or
follow-up.

Material and Methods

After obtaining Institution Review Board approval at our
institution, we conducted a retrospective review of all
patients who underwent endoscopic sinus surgery (ESS)
for CRS with or without nasal polyps from January 2012
to March 2015. All patients’ demographics, diagnosis,
management, and follow-up data were retrospectively
collected. In this study, patients diagnosed with
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unilateral AFRS were particularly analyzed. All patients who had a
history of previous sinonasal surgery were excluded.
Diagnosis of allergic fungal rhinosinusitis
Patients were diagnosed with AFRS upon fulfillment
of the five Bent and Khun criteria, namely (a) type 1
hypersensitivity reaction to fungal antigens; (b) nasal
polyposis; (c) characteristic CT scan findings including
hyperdense areas; (d) eosinophilic mucin; and (e) positive
fungal smear or culture.
Unilateral AFRS cases included those patients diagnosed
according to Bent and Khun criteria and who had strictly
unilateral involvement of the paranasal sinuses with the
contralateral side completely disease-free.
Endoscopic and computed tomography findings
Polyps were assessed endoscopically based on Meltzer’s et
al. [21] endoscopic grading system of nasal polyposis: grade
0, no visible polyps; grade 1, smallest-size polyps confined
within the middle meatus; grade 2, polyps occupying the
middle meatus; grade 3, polyps extending beyond the
middle meatus into the nasal cavity, but not reaching below
the inferior edge of the inferior turbinate; grade 4, polyps
filling up the nasal cavity.
In addition to the hyperdense areas on paranasal sinus
CT scan as part of the definition and inclusion criteria,
Lund–Mackay CT scores and bony erosions were also
documented.
Treatment and follow-up protocol for allergic fungal
rhinosinusitis
All AFRS patients were treated with preoperative oral steroids
followed by ESS with wide sinusotomies. We have a protocol
of giving oral steroids for 7 days before surgery (0.5 mg/kg of
prednisolone), and to continue it postoperatively in tapering
doses for 6–8 weeks (40 mg for 4 days, 30 mg for 4 days, 20
mg for 1 week, followed by 10 mg for 2–4 weeks). We also
supplement it with budesonide nasal irrigations (twice-daily
irrigations with 1 mg of budesonide mixed with 240 ml of
saline solution). Once the oral steroids are tapered, all patients were maintained on budesonide irrigations on the diseased sides.
After the initial weekly postoperative follow-up period,
patients were followed up monthly for the first 6 months and
then once in 3 months thereafter. On each follow-up visit,
nasal endoscopy was carried out to monitor any disease development. Boosts of short-course oral steroids were given in
cases with early detection of polyps. In cases of persistent
disease reported during follow-up, we have recorded the side
of the pathology (ipsilateral, contralateral, or both) and the
time of presentation with recurrent disease or contralateral
AFRS based on endoscopic and CT findings.
Statistical analysis
Statistical analyses were performed using IBM SPSS 22.0 for
Windows (IBM Corp., Armonk, New York, USA). The significance level was set at P greater than 0.05. The prevalence of
AFRS and unilateral AFRS was calculated. In unilateral AFRS,
we have performed descriptive analysis of age, sex, endoscopic grades, CT scores, duration of follow-up, outcome,
and time of presentation with recurrent or contralateral
AFRS. Although outside the focus of this study, recurrence
rate in bilateral AFRS was also documented and compared
with that of unilateral disease.

Results

A total of 136 CRS cases with or without nasal polyps were
managed by ESS at our institution over the studied time
frame. Out of these, 52 (38.2%) patients were diagnosed
with AFRS. After complete clinical and radiological evaluation,

16 (30.8%) AFRS cases were diagnosed as unilateral AFRS
with the contralateral side completely disease-free (Fig. 1a).
Out of the 16 unilateral AFRS cases, 12 (75%) patients were
female and four (25%) were male. Age of presentation
ranged from 18 to 50 years, with a mean±SD of 32.8±10.4
months. Mean±SD follow-up time was 24.8±9.8 months,
with a range of 12–44 months.
Preoperative endoscopic and computed tomography
findings in unilateral allergic fungal rhinosinusitis
cases
Preoperative polyp grades had a mean±SD of 3.0±0.44.
Preoperative Lund–Mackay scores had a mean±SD of
9.81±1.87. Bone erosions were detected in seven (43.8%)
cases: six cases with lamina papyracea erosion, and one case
with both lamina papyracea and skull base involvement.
Outcomes in unilateral allergic fungal rhinosinusitis
Out of the 16 unilateral AFRS cases reviewed, nine (56.2%)
patients remained free of disease during the follow-up period,
four (25%) patients had contralateral development of AFRS
(Fig. 1), two (12.5%) had ipsilateral recurrence of disease,
and one (6.25%) suffered from both ipsilateral recurrence
and contralateral development of AFRS (Table 1 and Fig. 2).
Therefore, a total of five (31.3%) patients had contralateral
development of disease, whereas three (18.8%) patients had
ipsilateral recurrence.
Although the occurrence of AFRS in the contralateral
(nonoperated)
side
was
higher
than
ipsilateral
recurrence (31.3 vs. 18.8%), the difference was not statistically
significant (P=0.41). Overall, 43.8% of patients required
another surgery for their recurrence and/or contralateral
AFRS. This pattern of recurrence and outcome is presented
in Table 1 and Fig. 2.
The time at which patients presented with contralateral
development of AFRS ranged from 6 to 29 months
postoperatively (mean±SD: 15±9.3 months). Time of
presentation with ipsilateral recurrence ranged from 13 to 24
months (mean±SD: 17.7±5.7 months).
Postoperative endoscopic and computed tomography
findings in unilateral allergic fungal rhinosinusitis
cases
Overall, postoperative polyp grades had a mean±SD of
1.0±1.2. Postoperative Lund–Mackay scores had a mean±SD
of 3.7±4.8. In patients with contralateral development and/
or ipsilateral recurrence of disease, polyp grades had a
mean±SD of 2.38±0.52, and Lund–Mackay scores had a
mean±SD of 7.4±1.5 (Lund–Mackay score was calculated
for each side separately in the single case that had bilateral
disease). One case with contralateral development of AFRS
also had lamina papyracea erosion (25%).
Recurrence in unilateral versus bilateral allergic
fungal rhinosinusitis
Although the information from bilateral AFRS cases is
beyond the focus of the current study, we have
documented the recurrence rate in bilateral AFRS patients
managed at our institution. Out of the 36 bilateral cases operated,
recurrence was reported in 22 (61.1%) patients. When
comparing unilateral and bilateral AFRS, the recurrence
rate in unilateral cases was significantly lower (18.8 vs.
61.1%; P=0.007). However, because of the contralateral
development of disease in 31.3% of the unilateral AFRS
cases, the final need for another surgical intervention did
not significantly differ between unilateral and bilateral AFRS
cases (43.8 vs. 61.1%, respectively; P=0.24).
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Table 1 Prevalence and outcome of allergic fungal rhinosinusitis (AFRS) among 136 CRS patients treated with endoscopic
sinus surgery (ESS) at our institution
Not AFRS:
84 (60.8%)
136
CRS
with
or
without
nasal
polyps treated with AFRS:
52 (38.2%)
ESS

Free: 14 (38.9%)

Bilateral:
36 (69.2%)
Unilateral:
16 (30.8%)

Diseased: 22 (61.1%)
Post-operative Follow up

Free: 9 (56.2%)
Diseased:
7 (43.8%)

Contralateral AFRS*: 4 (25%)
Ipsilateral Recurrence **: 2 (12.5%)
Bilateral AFRS* / **: 1 (6.25%)

AFRS, allergic fungal rhinosinusitis; CRS, chronic rhinosinusitis; ESS, endoscopic sinus surgery
aTotal incidence of contralateral disease in unilateral AFRS equals: contralateral AFRS+bilateral AFRS – i.e. 25+6.25=31.3%
bTotal incidence of recurrence in unilateral AFRS equals: ipsilateral recurrence+bilateral AFRS – i.e. 12.5+6.25=18.8%

Fig 1 (a) Preoperative computed tomography (CT) scan of left (unilateral) allergic fun
gal rhinosinusitis (AFRS) in a 22-year-old female patient
(b) CT scan obtained 10 months postoperatively when development of contralat
eral AFRS was noted during routine postoperative follow-up

Fig 2 Outcome in 16 cases of unilateral allergic fungal rhinosinusitis (AFRS) cases
during a mean postoperative duration of 24.8 months (range: 12–44 months)
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Table 2 Reported prevalence of unilateral allergic fungal rhinosinusitis cases and their recurrence (Rec) rate (whenever
described)
Studies
Current study

Total no. AFRS cases

N (%) of unilateral cases

52

16 (30.8)

Recurrence rate
For unilateral AFRS:
Contralateral AFRS: 31.3%
Ipsilateral recurrence: 18.8%
For bilateral AFRS: 61.1%

Zakirullah et al. [27]

23

16 (70)

18.75% for unilateral (vs. 85.7% of bilateral)

Al-Dousary [16]

59

20 (33.9)

Not studied

Thahim et al. [28]

20

12 (60)

Overalla 20%

Zhou et al. [29]

21

10 (47.6)

Overall 33.3%

Gupta et al. [30]

132 (>15 years)

38 (28.8)

Overall 9.8%

32

20 (62.5)

22.7% for unilateral (vs. 30% for bilateral)

100 (>17 years)

37

Not studied

Sohail et al [2]
McClay [31]
Ferguson et al. [32]

192

96 (50)

Not studied

Mukherji et al. [15]

45

22 (49)

Not studied

Torres et al. [33]

16

7 (44)

Not studied

AFRS, allergic fungal rhinosinusitis.
aRecurrence was reported for both unilateral and bilateral cases altogether.

Discussion

AFRS represents one of the distinctive forms of CRS with
characteristic clinical and pathological presentation. The
reported prevalence of AFRS among patients undergoing
ESS is widely variable, and it is generally thought to be
higher in warm and humid climates. In USA, it has been
estimated that 5–10% of patients with CRS carry a diagnosis of
AFRS. [22,23] A recent Iranian study found AFRS in 9.45%
of patients with sinonasal polyposis [24]. Goh et al. [25]
reported 26.7% prevalence of AFRS in adult Malaysian
patients with refractory CRS. In India, Saravanan et al. [26]
have studied 70 consecutive refractory CRS patients with or
without nasal polyps and found AFRS in almost 50% of their
studied sample. In another study in eastern Saudi Arabia, the
prevalence of AFRS among patients with nasal polyposis was
reported as 12.1% [20]. Our prevalence of AFRS was 38.2%,
and this relatively higher percentage may be related to
climate difference in our geographical area, or because of the
fact that our hospital is a tertiary/quaternary care center with
a tendency toward receiving more advanced and challenging
cases, which is more frequent in AFRS.
Unilateral predominance of AFRS is frequently described
in literature and has to be distinguished from strictly
unilateral disease. For example, Bent and Kuhn
reported 87% (13 out of 15) of their AFRS cases as unilaterally
predominant. Mukherji et al. [15] also documented
asymmetric involvement in 78% of bilateral cases. The
reported prevalence of true unilateral disease varies widely
from 28.8 to 70% of AFRS cases (Table 2), [2,15,16,27–33]
and our 30.8% prevalence of unilateral AFRS lies within this
range.
Since its description in the eighties of the last century, [3]
various studies have discussed the clinical presentation
and management of AFRS. However, many aspects of this
disease entity still remain incompletely understood. The
clinical behavior of unilateral AFRS cases is not an
exception. The recurrence rate in unilateral AFRS has been
seldom described. Zakirullah et al.[27] reported a recurrence
rate of 18.5 versus 85.7% in unilateral and bilateral cases,
respectively. However, Sohail et al. [2] found no statistically
significant difference among both entities (22.5 vs. 30%),
which might be because of their small sample size (Table 2).

In our study, the recurrence rate in unilateral AFRS cases was
significantly lower than bilateral disease (18.8 vs. 61.1%),
which may be explained by the theoretical less disease
severity in cases with unilateral involvement. However,
development of AFRS in the contralateral side affected the
clinical outcome so that the need for another surgery was not
statistically significant from bilateral cases.
To the best of our knowledge, none of the studies in
literature
has
exclusively
addressed
postoperative
behavior in unilateral AFRS cases. In the current study, the
clinical outcome of unilateral AFRS patients managed at our
institution over the preceding 3 years was investigated. In
addition to ipsilateral recurrence in 12.5% of cases, another
25% have developed contralateral AFRS within 29 months
after ESS (mean: 15 months). Furthermore, 1 (6.25%)
patient presented with both ipsilateral recurrence and
contralateral AFRS.
The reason for this contralateral development of AFRS is not
clear, but it may be part of the natural disease process. We
postulate that unilateral AFRS is an early stage in disease
presentation that can eventually progress to bilateral disease.
Contralateral development of AFRS may also be theoretically
explained as the transfer of fungal antigens from the affected
side to the healthy side because of intraoperative or postoperative irrigations. Nevertheless, this phenomenon should
alert the surgeon that future development of contralateral
AFRS needs to be part of patients’ preoperative counseling.
In addition, postoperative follow-up should be directed to
both sinonasal passages.
A challenging question arises whether providing a
prophylactic treatment to the contralateral side may
have a role in certain cases such as aggressive disease or
questionable follow-up. Clearly, current study findings do
not justify operating normal uninvolved sides. The need for
postoperative nasal sprays or local irrigation for both sides of
the nose can be argued, and further investigation is needed.
Whether treatment of the uninvolved side can be valuable in
preventing future development of AFRS remains a question
that definitely requires further research.
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Conclusion

Postoperative development of contralateral AFRS is not
infrequent and needs to be part of patients’
counseling. Follow-up should be directed to both sinonasal
passages to detect early development of contral ateral disease or
recurrence. The effect of current study findings on
unilateral AFRS treatment plan requires further prospective
studies, preferably with multicenter collaboration.
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